Andrew J. Plodkowski

11.3k total citations · 3 hit papers
85 papers, 3.7k citations indexed

About

Andrew J. Plodkowski is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrew J. Plodkowski has authored 85 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 42 papers in Oncology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrew J. Plodkowski's work include Lung Cancer Treatments and Mutations (50 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Andrew J. Plodkowski is often cited by papers focused on Lung Cancer Treatments and Mutations (50 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Andrew J. Plodkowski collaborates with scholars based in United States, Spain and Canada. Andrew J. Plodkowski's co-authors include Matthew D. Hellmann, Darragh Halpenny, Hira Rizvi, Jamie E. Chaft, Kathryn C. Arbour, Niamh M. Long, Gregory J. Riely, Ai Ni, Charles M. Rudin and Mark G. Kris and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew J. Plodkowski

81 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

2018 712 citations Kathryn C. Arbour, Niamh M. Long et al. profile →
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

2018 631 citations Matthew D. Hellmann, Darragh Halpenny et al. Annals of Oncology profile →
Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

2016 327 citations Alexander Drilon, Natasha Rekhtman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew J. Plodkowski United States	25	2.5k	1.9k	909	502	388	85	3.7k
Shaodong Hong China	28	2.9k 1.1×	1.8k 1.0×	619 0.7×	605 1.2×	542 1.4×	128	3.9k
Aurélie Cazes France	32	1.5k 0.6×	1.6k 0.9×	957 1.1×	727 1.4×	627 1.6×	108	3.8k
J. Mezger Germany	18	1.9k 0.8×	1.7k 0.9×	746 0.8×	351 0.7×	228 0.6×	53	3.4k
Fariba Navid United States	31	896 0.4×	1.3k 0.7×	686 0.8×	298 0.6×	318 0.8×	104	2.8k
Marie Christine Aubry United States	29	1.3k 0.5×	1.4k 0.8×	598 0.7×	368 0.7×	186 0.5×	102	2.9k
Hyunseok Kang United States	28	2.0k 0.8×	889 0.5×	772 0.8×	540 1.1×	336 0.9×	102	3.4k
Roberto Petrioli Italy	28	1.6k 0.6×	1.2k 0.7×	508 0.6×	407 0.8×	248 0.6×	135	3.1k
Eva Lieto Italy	31	1.7k 0.7×	1.1k 0.6×	625 0.7×	443 0.9×	412 1.1×	67	3.1k
Feng‐Hua Wang China	31	1.5k 0.6×	861 0.5×	872 1.0×	822 1.6×	232 0.6×	126	2.9k
Tatsuya Yoshida Japan	23	1.3k 0.5×	1.3k 0.7×	469 0.5×	346 0.7×	215 0.6×	168	2.5k

Countries citing papers authored by Andrew J. Plodkowski

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Plodkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Plodkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Plodkowski more than expected).

Fields of papers citing papers by Andrew J. Plodkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Plodkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Plodkowski. The network helps show where Andrew J. Plodkowski may publish in the future.

Co-authorship network of co-authors of Andrew J. Plodkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Plodkowski. A scholar is included among the top collaborators of Andrew J. Plodkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Plodkowski. Andrew J. Plodkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elkrief, Arielle, Alex Makhnin, Linda S. Ahn, et al.. (2023). Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR -Mutant Lung Adenocarcinomas. Clinical Cancer Research. 29(8). 1423–1428. 1 indexed citations

Solomon, James P., Soo‐Ryum Yang, Noura J. Choudhury, et al.. (2022). Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors. Clinical Cancer Research. 28(21). 4649–4659. 12 indexed citations

Schoenfeld, Adam J., Hira Rizvi, Danish Memon, et al.. (2022). Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer. Clinical Cancer Research. 28(17). 3797–3803. 31 indexed citations

Luo, Jia, Song Wu, Hira Rizvi, et al.. (2022). Deciphering radiological stable disease to immune checkpoint inhibitors. Annals of Oncology. 33(8). 824–835. 24 indexed citations

Wu, Abraham J., Andrew J. Plodkowski, Michelle S. Ginsberg, et al.. (2022). Detection of COVID-19 pulmonary manifestations with radiotherapy simulation CT imaging. Clinical Imaging. 93. 83–85.

Arbour, Kathryn C., Hira Rizvi, Andrew J. Plodkowski, et al.. (2021). Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 27(8). 2209–2215. 82 indexed citations

Araújo-Filho, José de Arimateia Batista, Jason C. Chang, María Mayoral, et al.. (2021). Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?. Lung Cancer. 153. 158–164. 5 indexed citations

Alessi, Joao V., Biagio Ricciuti, Fangxin Hong, et al.. (2020). Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status. Journal for ImmunoTherapy of Cancer. 8(2). e001007–e001007. 40 indexed citations

Paik, Paul K., Rachel K. Kim, Linda S. Ahn, et al.. (2020). A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers. Clinical Cancer Research. 26(8). 1796–1802. 10 indexed citations

10.

Plodkowski, Andrew J., Dipti Gupta, Yulia Lakhman, et al.. (2020). Diagnostic utility and clinical implication of late gadolinium enhancement cardiac magnetic resonance for detection of catheter associated right atrial thrombus. Clinical Imaging. 62. 17–22. 4 indexed citations

11.

Pérez-Johnston, Rocío, Andrew J. Plodkowski, Darragh Halpenny, et al.. (2020). Perfusion defects on dual-energy CTA in patients with suspected pulmonary embolism correlate with right heart strain and lower survival. European Radiology. 31(4). 2013–2021. 10 indexed citations

12.

Linehan, W. Marston, Adam J. Schoenfeld, Viola W. Zhu, et al.. (2019). Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhibitors. Journal of Thoracic Oncology. 15(2). 258–265. 54 indexed citations

13.

Santini, Fernando C., Hira Rizvi, Andrew J. Plodkowski, et al.. (2018). Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC. Cancer Immunology Research. 6(9). 1093–1099. 263 indexed citations

14.

Arbour, Kathryn C., Andrew J. Plodkowski, Hira Rizvi, et al.. (2018). MA19.09 Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB. Journal of Thoracic Oncology. 13(10). S424–S424. 24 indexed citations

15.

Linehan, W. Marston, Viola W. Zhu, Adam J. Schoenfeld, et al.. (2018). Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC. Journal of Thoracic Oncology. 13(10). 1530–1538. 54 indexed citations

16.

Halpenny, Darragh, Andrew J. Plodkowski, Gregory J. Riely, et al.. (2016). Radiogenomic evaluation of lung cancer — Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations?. Clinical Imaging. 42. 147–151. 14 indexed citations

17.

Drilon, Alexander, Isabella Bergagnini, Lukas Delasos, et al.. (2016). Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers. Annals of Oncology. 27(7). 1286–1291. 87 indexed citations

18.

Plodkowski, Andrew J., Alexander Drilon, Darragh Halpenny, et al.. (2015). From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?. Lung Cancer. 90(2). 321–325. 27 indexed citations

19.

Cunningham, Jane, Andrew J. Plodkowski, Dilip D. Giri, & Sinchun Hwang. (2015). Case report of malignant pulmonary parenchymal glomus tumor: imaging features and review of the literature. Clinical Imaging. 40(1). 144–147. 8 indexed citations

20.

Plodkowski, Andrew J., Catherine L. Hayter, Theodore T. Miller, Joseph Nguyen, & Hollis G. Potter. (2012). Lamellated Hyperintense Synovitis: Potential MR Imaging Sign of an Infected Knee Arthroplasty. Radiology. 266(1). 256–260. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact